Jefferies reiterated a Buy rating on Align Technology ALGN and increased its price target from $34 to $36.
Jefferies noted, “The mid-point of ALGN's initial 3Q12 financial outlook contemplates a 20% core Invisalign case volume growth experience (vs. our prior +16%), reflecting a continuation of healthy demand trends globally. The mid-point of its formal 3Q12 revenue outlook ($139M / +10%) fell ~4% shy of the consensus view on a lower (implied) ASP expectation that we attribute, in part, to an estimated 3% FX headwind, and to a lesser degree, other discrete items. We perceive little evidence to support the notion that such an implied ASP outcome is a function of heightened competitive dynamics.”
Align Technology closed at $31.70 on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in